WeLeader Biomedical Statistics

Total Valuation

TPEX:7713 has a market cap or net worth of TWD 3.16 billion. The enterprise value is 3.74 billion.

Market Cap	3.16B
Enterprise Value	3.74B

Important Dates

The last earnings date was Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	Jun 3, 2025

Share Statistics

TPEX:7713 has 45.48 million shares outstanding. The number of shares has increased by 3.71% in one year.

Current Share Class	45.48M
Shares Outstanding	45.48M
Shares Change (YoY)	+3.71%
Shares Change (QoQ)	+4.69%
Owned by Insiders (%)	19.91%
Owned by Institutions (%)	2.30%
Float	9.29M

Valuation Ratios

The trailing PE ratio is 17.12.

PE Ratio	17.12
Forward PE	n/a
PS Ratio	3.09
PB Ratio	2.91
P/TBV Ratio	2.92
P/FCF Ratio	21.79
P/OCF Ratio	10.40
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.15, with an EV/FCF ratio of 25.77.

EV / Earnings	21.33
EV / Sales	3.66
EV / EBITDA	11.15
EV / EBIT	17.16
EV / FCF	25.77

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.65.

Current Ratio	1.46
Quick Ratio	1.00
Debt / Equity	0.65
Debt / EBITDA	2.11
Debt / FCF	4.88
Interest Coverage	36.16

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	12.83%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, TPEX:7713 has paid 43.76 million in taxes.

Income Tax	43.76M
Effective Tax Rate	19.98%

Stock Price Statistics

The stock price has increased by +1.16% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+1.16%
50-Day Moving Average	63.50
200-Day Moving Average	67.10
Relative Strength Index (RSI)	73.33
Average Volume (20 Days)	31,485

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:7713 had revenue of TWD 1.02 billion and earned 175.26 million in profits. Earnings per share was 4.06.

Revenue	1.02B
Gross Profit	323.63M
Operating Income	217.88M
Pretax Income	219.02M
Net Income	175.26M
EBITDA	255.48M
EBIT	217.88M
Earnings Per Share (EPS)	4.06

Full Income Statement

Balance Sheet

The company has 130.69 million in cash and 707.67 million in debt, giving a net cash position of -576.98 million or -12.69 per share.

Cash & Cash Equivalents	130.69M
Total Debt	707.67M
Net Cash	-576.98M
Net Cash Per Share	-12.69
Equity (Book Value)	1.09B
Book Value Per Share	23.89
Working Capital	197.75M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 303.82 million and capital expenditures -158.78 million, giving a free cash flow of 145.04 million.

Operating Cash Flow	303.82M
Capital Expenditures	-158.78M
Free Cash Flow	145.04M
FCF Per Share	3.19

Full Cash Flow Statement

Margins

Gross margin is 31.68%, with operating and profit margins of 21.33% and 17.15%.

Gross Margin	31.68%
Operating Margin	21.33%
Pretax Margin	21.44%
Profit Margin	17.15%
EBITDA Margin	25.01%
EBIT Margin	21.33%
FCF Margin	14.20%

Dividends & Yields

This stock pays an annual dividend of 3.37, which amounts to a dividend yield of 4.85%.

Dividend Per Share	3.37
Dividend Yield	4.85%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	141.97%
Buyback Yield	-3.71%
Shareholder Yield	1.14%
Earnings Yield	5.54%
FCF Yield	4.59%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:7713 has an Altman Z-Score of 2.79 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.79
Piotroski F-Score	3